The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of PLX038 in patients with platinum resistant ovarian, primary peritoneal and fallopian tube cancer.
 
Andrea Elisabeth Wahner Hendrickson
Consulting or Advisory Role - Oxcia
Research Funding - Amgen (Inst); Elucida Oncology; ProLynx (Inst); Torl Biotherapeutics
 
Nathan R. Foster
No Relationships to Disclose
 
Tracy Clasemann
No Relationships to Disclose
 
Megan Grudem
No Relationships to Disclose
 
Carolyn Klampe
No Relationships to Disclose
 
Matthew Stephen Block
Research Funding - Alkermes; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Marker, Inc. (Inst); Merck (Inst); nference; Pharmacyclics (Inst); Regeneron; Sorrento Therapeutics (Inst); TILT Biotherapeutics; Transgene (Inst); Viewpoint Molecular Targeting
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Aminah Jatoi
Consulting or Advisory Role - meter health (Inst); Pfizer (Inst)
Research Funding - AstraZeneca (Inst)
 
Saravut John Weroha
Research Funding - Genentech; KIYATEC; Novartis; Tesaro
Patents, Royalties, Other Intellectual Property - Kiyatec; Mayo Clinic Ventures Ovarian Cancer PDX Models
Travel, Accommodations, Expenses - Merck
(OPTIONAL) Uncompensated Relationships - KIYATEC
 
Grace Mei Yee Choong
No Relationships to Disclose
 
Siddhartha Yadav
Research Funding - AstraZeneca (Inst); REPARE Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Lynn M Flickinger
Employment - Mayo Clinic Cancer Center
 
Gary W Ashley
Employment - Prolynx, Inc
Leadership - Prolynx, Inc
Stock and Other Ownership Interests - ProLynx, Inc
Research Funding - ProLynx, Inc
Patents, Royalties, Other Intellectual Property - Prolynx, Inc
 
Peter J. Langecker
Employment - Caidya CRO
Leadership - Angarus Therapeutics
Stock and Other Ownership Interests - Angarus Therapeutics; Prolynx Inc
 
Daniel V Santi
Employment - ProLynx Inc
Leadership - ProLynx Inc
Stock and Other Ownership Interests - ProLynx, Inc
Patents, Royalties, Other Intellectual Property - ProLynx, Inc
 
Scott H. Kaufmann
Consulting or Advisory Role - Attavare
Research Funding - Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Mayo Clinic holds a patent on an antibody developed in the Kaufmann laboratory. (Inst)
(OPTIONAL) Uncompensated Relationships - ProLynx